Vicarious Surgical (RBOT) Preferred Stock Liabilities (2020 - 2021)
Vicarious Surgical (RBOT) reported Preferred Stock Liabilities of $275.6 million for Q2 2021, down 7.09% on a QoQ basis from $296.6 million in Q1 2021.
Vicarious Surgical (RBOT) has 2 years of Preferred Stock Liabilities data on file, last reported at $275.6 million in Q2 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $275.6 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $275.6 million (changed N/A YoY) and the FY2020 annual result came in at $299.8 million, changed N/A from the prior year.
- Preferred Stock Liabilities retreated to $275.6 million in Q2 2021 per RBOT's latest filing, from $296.6 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $329.3 million in Q3 2020 and bottomed at $275.6 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 275.59 Mn |
| Mar 31, 2021 | 296.62 Mn |
| Dec 31, 2020 | 299.80 Mn |
| Sep 30, 2020 | 329.26 Mn |